議程概要
| 2011年1月26日(星期三)—研究會日程 | ||||||||||
| 8:30 | Registration & Morning Coffee | |||||||||
| 9:30 | Workshops Begin | |||||||||
| 11:30 | 30 Minutes Networking Break | |||||||||
| 1pm | End of Half-Day Workshop / Luncheon for Workshops Participants | |||||||||
| 2:30 | Full-Day Workshops Continue & Partnerships Pit Stops Begin | |||||||||
| 3:30 | Networking Break | |||||||||
| 5:00 | Full-Day Workshops & Partnerships Pit Stops Conclude | |||||||||
| 5:00 | Opening Night Partnerships Reception | |||||||||
|
||||||||||
| 1:00 – 5:00 | DDP Networking Experience: Partnering Pit Stops | |||||||||
| 5:00 | Opening Night Partnerships Reception | |||||||||
| 2011年1月27日（星期四）—會議第1天 | ||||||||||
| 7:00 | Registration & Morning Coffee/Partnering Meetings | |||||||||
| 8:00 | Chairperson Kick-Off Tying Innovation to Value—
Where We’ve Been and Where We’re Going Lee Shorter, Open Innovation Team, R&D, GLAXOSMITHKLINE Bob Nissen, Former Vice President, Business Development & Licensing, NOVARTIS, President, NISSEN CONSULTING |
|||||||||
| 8:15 | Back from the Brink: Explore Self-Marketing as the
Only Viable Long-Term Business Option to Maintain
Access to Capital David Steinberg, Managing Director, Equity Research, Specialty Pharmaceuticals & Drug Delivery, DEUTSCHE BANK |
|||||||||
| 9:00 | C-Suite Unplugged: Communicating the Value of
Drug Delivery to Secure Long-Term Roles in Pharma
Pipelines Moderator: Philip Green, Senior Director, Drug Delivery Services, Merck Bioventures, MERCK RESEARCH LABORATORIES Peter Richardson, Chief Scientific Officer, MANNKIND CORPORATION John Fraher, Chief Commercial Officer, EURAND |
|||||||||
| 9:45 | DDP Technology Showcase - GSK's Proprietary Drug Delivery Programme - The Development and Commercialization of Innovative Technologies | |||||||||
| 10:00 | Grand Opening of Partnering Hall | |||||||||
| 10:45 |  Getting It Done: Breaking the Stalemate to Make
Way for Health Reform and What the End Result
Will Mean for You and Your BusinessTom Daschle, Former Senate Majority Leader, UNITED STATES SENATE, Author, “Getting it Done: How Obama and Congress Finally Broke the Stalemate to Make Way for Health Care Reform” |
|||||||||
| 11:15 | DDP Technology Showcase- Biochemics Presents Transdermal Delivery Using Biophysical Modulation |
|||||||||
| 11:30 | Networking Break & Meet & Greet Book Signing with Senator Tom Daschle | |||||||||
| 11:45 | The Decision Tree: Interpret and Analyze Patient
Behavior and Decision-Making to Create
Innovative Technology and Product Design Thomas Goetz, Author, “The Decision Tree: Taking Control of Your Health in the New Era of Personalized Medicine” Executive Editor, WIRED MAGAZINE |
|||||||||
| 12:30 | DDP Speed Networking / Business Discussion Luncheon & Meet & Greet Book Signing with Thomas Goetz | |||||||||
| 歷程 | A
以成長和可持續為目標的交易與事業開發 |
B
開發生命週期管理和價值導向的產品 |
C
專利失效的藥物傳遞之新領域 |
D
新藥物傳遞技術 |
||||||
| 2:00 | Filling Technology Gaps Determines When to Do
Things In-House and When to Seek Partners Michael Cucolo, Director, Strategy, Alliances, and Transactions BRISTOL MYERS SQUIBB Danchen Gao, Director, New Drug Development, ANCHEN PHARMACEUTICALS |
Meet the New Standards of Drug Delivery Safety
& Efficacy to Achieve Successful Targeted
Delivery David Monteith, PhD, MBA, Senior Director, Drug Delivery & Life Cycle Development, SCHERING-PLOUGH Riccardo Panicucci, PhD, Global Head of Chemical & Pharmaceutical Profiling,NOVARTIS INSTITUTE FOR BIOMEDICAL RESEARCH INC. |
From Idea to Commercial – Building a Specialty
Pharma Company Around the Development of the
Worlds’ First Single Use, Disposable, Needle Free
Migraine Drug Delivery System Jonathan Rigby, Co-Founder & Vice President, Business Development, ZOGENIX INC |
Flex Medical’s Incorporating Digital and Wireless Technology to Enable Drug Delivery Innovations Lior Shtram, Director, Technology Management, FLEX MEDICAL |
||||||
| 2:45 | Identify Mature Partnering Opportunities with Academic Institutions Arundeep S. Pradhan, Associate Vice President, Technology Transfer and Business Development, OREGON HEALTH & SCIENCE UNIVERSITY Brian Windsor, SVP, Portfolio Management EMERGENT TECHNOLOGIES |
Moving from “Different and More Expensive” to Dr. John Fox, Chief Development Officer, MERRION PHARMACEUTICALS Robin Hwang, Vice President, Head of Drug Delivery Devices, HALOZYME THERAPEUTICS |
Translate Advances in Pulmonary Delivery
Systems to Remain Competitive |
Microcor™: A New Generation In Transdermal
Delivery Peter Staple, President and CEO, CORIUM |
||||||
| 3:30 | Networking Break | |||||||||
| 4:15 | Build the Foundation for Successful
Collaborations: R&D Partnering with BD –
from Opportunity Evaluation and through the
Collaboration Julia Rashba-Step, Director, Advanced Drug Delivery, PFIZER, INC. Lawrence M. Zaccaro, Associate Director, Research & Development, Business Development, PFIZER INC. |
External Technology Based Drug Delivery
Feasibility Studies For Pipeline Molecules
Snehlata Mascarenhas, Project Management Consultant - Drug Delivery ELI LILLY AND COMPANY |
Fill the Technological Gap: Leverage Advances in
Gastroretentive Formulations to Grow Your Portfolio
Sujit Basu, Sr. Director, Formulation, DICERNA PHARMACEUTICALS Bo Allen, Chairman & CEO, VERSALION PHARMACEUTICALS Peter Kramer, Former Executive Director, Technology Transactions, BRISTOL-MEYERS SQUIBB PHARMACEUTICALS |
GIPET Technology For Absorption Enhancement,
Delivering Unique Products Tom Leonard, Chief Scientific Officer, MERRION PHARMACEUTICALS |
||||||
| 5:00 | Contract and Negotiate for Optimal Sharing of IP
Rights with Your Partners Balu Gupta, Global Head, Patent Operations, DR. REDDY ’S PHARMACEUTICALS Philip Strassburger, Vice President and Intellectual Property Counsel, PURDUE PHARMA |
Overcome Slowing Speed to Market
Challenges by Identifying Technology Ripe For
Commercialization Vickie O’Neill, Drug Delivery, UPSHER-SMITH LABORATORIES, INC. Manohar Katakam, PhD, Director, New Products, PFIZER |
Debate When Parenteral Delivery Still Makes
Sense Over Oral Delivery |
ViaDerm Transdermal Drug Delivery Judith Kornfeld, VP, Business Development, TRANSPHARMA |
||||||
| 5:45 | DDP 15th Anniversary Reception | |||||||||
| 2011年1月28日（星期五）—會議第2天 | ||||||||||
| 8:00 | Morning Coffee & Partnering Meetings | |||||||||
| 9:00 | Day One Recap
Vik Seoni, Vice Pres Head of Business Development, ELAN DRUG TECHNOLOGIES |
|||||||||
| 9:15 | The Emotion Behind Invention Dean Kamen, Inventor, Entrepeneur, Advocate & Founder, DEKA RESEARCH |
|||||||||
| 10:00 | DDP Technology Showcase - PANTEC Solutions Injection Free Intraepidermal Drug Delivery for Home Use Christof Boehler, CEO, PANTEC |
|||||||||
| 10:15 | Partnering in the Changed Pharmaceutical Environment Debra Bingham, Partner, VALEO PARTNERS Keith Horspool, Vice President, Parhamceutics, BOEHRINGER INGELHEM Brett Zbar, MD, Partner, AISLING CAPITAL |
|||||||||
| 11:00 |  2nd Annual Drug Delivery Partnerships Awards |
|||||||||
| 歷程 | A 以成長和可持續為目標的交易與事業開發 |
B 專利失效的藥物傳遞之新領域 |
||||||||
| 11:30 | Part I: Globalization of Drug Delivery: Assess Business Opportunities in Emerging Markets to Expand International Markets Share: Who? What? Where? |
Focus on The Continued Growth of Biologics: Tackle Challenges to Deliver High Protein Content in Small Volume Dosages Peter Hoffmann, PhD, Vice President, New Technology Development, GENZYME PHARMACEUTICALS Anand Subramony, PhD, Principal Fellow & Head Novel Delivery Technologies & Therapeutics(NDT), NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. |
||||||||
| 12:15 | For Better or For Worse: Making Partnerships Last Patrick Gallagher, Vice President, Business Development, NOVEN PHARMACEUTICALS |
The Business Of Biosimilars: Evaluate Regulatory Implications To Ensure Safety, Quality, And Efficacy Mathias Romacker, Principal Business Analyst, AMGEN Gerhard Mayer, Director, International Product Management, BAYER HEALTHCARE PHARMACEUTICALS Tom Haverty, MD, Vice President, Merck Bioventures and Early Biologics, MERCK RESEARCH LABORATORIES |
||||||||
| 1:00 | Build and Maintain Alignment with Your Partners to Permit Constructive Collaboration to Progress
Pipeline Quickly and Efficiently Michael Haller, Vice President, Alliance Management & Head, Drug Delivery Franchise, HALOZYME THERAPEUTICS Mark Wilson, Director, Collaboration Management, Europe, GLAXOSMITHKLINE |
Advances in Therapeutic Nanoparticles for Drug Delivery in Cancer Neil Desai, Vice President, Research & Development, ABRAXIS BIOSCIENCE LLC |
||||||||
| 1:30 | Optional Lunch (See pricing details on page 11 of the brochure) | |||||||||
| 2:30 | One-on-One Partnering Meetings Afternoon | |||||||||
| 4:30 | Finish Line - Close of the 15th Annual DDP. See you in 2012! | |||||||||